Table 1.
Demographic and Clinical Characteristics of the Study Groups
| Group 1 (n=43) | Group 2 (n=32) | P value | |
|---|---|---|---|
| Age (years) | 34.7 ± 13.2 | 47.2 ± 10.6 | <0.001* |
| Age groups | |||
| 50–65 | 8 (40) | 12 (60) | 0.117* |
| <50 | 35 (63.6) | 20 (36.4) | |
| Gender | |||
| Female | 12 (27.9) | 11 (34.4) | 0.728** |
| Male | 31 (72.1) | 21 (65.6) | |
| Presence of symptoms | 6 (14.0) | 32 (100.0) | <0.001** |
| Type of symptoms | |||
| Fever | 0 (0.0) | 24 (75.0) | 0.001** |
| Fatigue | 1 (16.7) | 5 (15.6) | 0.999** |
| Cough | 2 (33.3) | 16 (50.0) | 0.663** |
| Dyspnea | 0 (0.0) | 18 (56.2) | 0.021** |
| Diarrhea | 2 (33.3) | 5 (15.6) | 0.302** |
| Nausea and vomiting | 0 (0.0) | 4 (12.5) | 0.999** |
| Others | 1 (16.7) | 6 (18.8) | 0.999** |
| Outcome | 0.427** | ||
| Survival | 43 (100.0) | 31 (96.9) | |
| Mortality | 0 (0.0) | 1 (3.1) |
Notes: Bold numbers emphasize significant p values *independent samples t-test **Pearson’s Chi-Square, Fisher’s Exact, or Fisher-Freeman-Halton test.